Metraipolis › archive › dc_59b06aa6b673

Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer — Europe PMC PMID:41744863

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41744863
DOI
10.3390/curroncol33020099
License (as archived)
solo-consultazione
Archived
2026-11-06T03:36:05.760Z
SHA-256 of the archived text
fca49c92fb2292c55d9c352170c954a0ab5da9ef09d5c8f5614abe537ba63b57
Stable URL of this page
https://metraipolis.com/documento/dc_59b06aa6b673

How to cite

Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer — Europe PMC PMID:41744863 — Europe PMC (en), https://europepmc.org/article/MED/41744863 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_59b06aa6b673 (Metraipolis archive dc_59b06aa6b673, sha256 fca49c92fb2292c55d9c352170c954a0ab5da9ef09d5c8f5614abe537ba63b57)
BibTeX
@misc{dc59b06aa6b673,
  title = {Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer — Europe PMC PMID:41744863},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41744863},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_59b06aa6b673; sha256 fca49c92fb2292c55d9c352170c954a0ab5da9ef09d5c8f5614abe537ba63b57},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41744863. Agents can read the archived copy with the MCP tool read_document.